Literature DB >> 17113268

DRD2 C957T polymorphism interacts with the COMT Val158Met polymorphism in human working memory ability.

Haiyan Xu1, Christoph B Kellendonk, Eleanor H Simpson, John G Keilp, Gerard E Bruder, H Jonathan Polan, Eric R Kandel, T Conrad Gilliam.   

Abstract

The C957T polymorphism in the dopamine D2 receptor (DRD2) gene and the Val158Met polymorphism in the Catechol-O-Methyl-Transferase (COMT) gene affect dopamine transmission and have been found to be associated with schizophrenia. Since DRD2 in mice and the COMT gene in humans modulate working memory, we examined the relationship and possible interaction of both polymorphisms to working memory performance in 188 healthy adults. Subjects having the DRD2 C/C allele showed the poorest performance in a word serial position test. Moreover, the effect of the C957T genotype was strengthened when interaction with the COMT Val158Met polymorphism was included in the analysis. We propose that an interaction of the DRD2 C957T and COMT Val158Met may be involved in the generation of some working memory deficits in schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17113268     DOI: 10.1016/j.schres.2006.10.001

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  28 in total

1.  Caudate Volume in Offspring at Ultra High Risk for Alcohol Dependence: COMT Val158Met, DRD2, Externalizing Disorders, and Working Memory.

Authors:  Shirley Y Hill; Sarah Lichenstein; Shuhui Wang; Howard Carter; Michael McDermott
Journal:  Adv J Mol Imaging       Date:  2013-10-01

2.  Genetic and vascular modifiers of age-sensitive cognitive skills: effects of COMT, BDNF, ApoE, and hypertension.

Authors:  Naftali Raz; Karen M Rodrigue; Kristen M Kennedy; Susan Land
Journal:  Neuropsychology       Date:  2009-01       Impact factor: 3.295

3.  Updated findings of the association and functional studies of DRD2/ANKK1 variants with addictions.

Authors:  Yunlong Ma; Wenji Yuan; Xianzhong Jiang; Wen-Yan Cui; Ming D Li
Journal:  Mol Neurobiol       Date:  2014-08-20       Impact factor: 5.590

Review 4.  A possible role for the striatum in the pathogenesis of the cognitive symptoms of schizophrenia.

Authors:  Eleanor H Simpson; Christoph Kellendonk; Eric Kandel
Journal:  Neuron       Date:  2010-03-11       Impact factor: 17.173

Review 5.  Genetic influence on the working memory circuitry: behavior, structure, function and extensions to illness.

Authors:  Katherine H Karlsgodt; Peter Bachman; Anderson M Winkler; Carrie E Bearden; David C Glahn
Journal:  Behav Brain Res       Date:  2011-08-22       Impact factor: 3.332

6.  COMT Val158Met Genotype and Individual Differences in Executive Function in Healthy Adults.

Authors:  Heather A Wishart; Robert M Roth; Andrew J Saykin; C Harker Rhodes; Gregory J Tsongalis; Kristine A Pattin; Jason H Moore; Thomas W McAllister
Journal:  J Int Neuropsychol Soc       Date:  2010-12-10       Impact factor: 2.892

7.  A polymorphism in the dysbindin gene (DTNBP1) associated with multiple psychiatric disorders including schizophrenia.

Authors:  Joanne Voisey; Christopher D Swagell; Ian P Hughes; Jason P Connor; Bruce R Lawford; Ross M Young; C Phillip Morris
Journal:  Behav Brain Funct       Date:  2010-07-09       Impact factor: 3.759

8.  Motor impulsivity in Parkinson disease: associations with COMT and DRD2 polymorphisms.

Authors:  David A Ziegler; Paymon Ashourian; Julien S Wonderlick; Alison K Sarokhan; Drazen Prelec; Clemens R Scherzer; Suzanne Corkin
Journal:  Scand J Psychol       Date:  2014-04-21

9.  Dopamine 2 Receptor Genes Are Associated with Raised Blood Glucose in Schizophrenia.

Authors:  Bruce R Lawford; Mark Barnes; C Phillip Morris; Ernest P Noble; Phillip Nyst; Karen Heslop; Ross McD Young; Joanne Voisey; Jason P Connor
Journal:  Can J Psychiatry       Date:  2016-04-06       Impact factor: 4.356

Review 10.  Brain plasticity and genetic factors.

Authors:  Kristin M Pearson-Fuhrhop; Jeffrey A Kleim; Steven C Cramer
Journal:  Top Stroke Rehabil       Date:  2009 Jul-Aug       Impact factor: 2.119

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.